Results 81 to 90 of about 20,748 (167)
Profile of pomalidomide and its potential in the treatment of myelofibrosis
Krisstina L Gowin, Ruben A Mesa Division of Hematology and Medical Oncology, Mayo Clinic Arizona, Scottsdale, AZ, USA Abstract: Myelofibrosis, a Philadelphia-negative myeloproliferative neoplasm, is in a new treatment era after the discovery of ...
Gowin KL, Mesa RA
doaj
Successful Management of Lupus‐Associated Autoimmune Myelofibrosis with Tofacitinib: A Case Report
We report a case of a 34‐year‐old woman with systemic lupus erythematosus (SLE) who developed thrombocytopenia and was diagnosed with lupus‐associated autoimmune myelofibrosis.
Hamidreza Soltani, Ali Dehghan
doaj +1 more source
Background Segregated-nucleus-containing atypical monocytes have recently been identified in mice. Segregated-nucleus-containing atypical monocytes are thought to originate from the bone marrow and induce fibrosis in the drug-injured lung.
Shunsuke Homma +11 more
doaj +1 more source
Cutaneous Extramedullary Hematopoiesis in Primary Myelofibrosis: A Case Report With Rapidly Fatal Outcome. [PDF]
El Bouhmadi A +4 more
europepmc +1 more source
Clinical and hematological profile of patients with philadelphia-negative myeloproliferative neoplasms: First report from the Ecuadorian registry. [PDF]
Freire C +8 more
europepmc +1 more source
CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms. [PDF]
Demoy M +14 more
europepmc +1 more source

